Weiwei Mu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Nanowire Synthesis and Applications
Papers in
-
- Nanoplatforms for cancer theranostics 19
- Nanowire Synthesis and Applications 5
- Immunology 17
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 6
- Immune Cell Function and Interaction 4
- Co-authors
- Na Zhang (31 shared papers)Yongjun Liu (24 shared papers)Qihui Chu (6 shared papers)Shuang Liang (19 shared papers)Shunli Fu (19 shared papers)Tong Gao (18 shared papers)Zipeng Zhang (16 shared papers)Kunji Chen (7 shared papers)
- Journals
- ACS Applied Materials & Interfaces (5 papers)ACS Nano (4 papers)Advanced Science (3 papers)Nature Communications (2 papers)Nano-Micro Letters (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Weiwei Mu
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Biomaterials 329
- Biomedical Engineering 616
- Immunology 284
- Oncology 205
- Pharmaceutical Science 37
Countries citing papers authored by Weiwei Mu
This map shows the geographic impact of Weiwei Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Mu more than expected).
Fields of papers citing papers by Weiwei Mu
This network shows the impact of papers produced by Weiwei Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Mu. The network helps show where Weiwei Mu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 255 | |
| 2 | 2023 | 62 | |
| 3 | 2016 | 61 | |
| 4 | 2019 | 61 | |
| 5 | 2020 | 51 | |
| 6 | 2013 | 47 | |
| 7 | 2020 | 43 | |
| 8 | 2018 | 39 | |
| 9 | 2021 | 37 | |
| 10 | 2011 | 37 | |
| 11 | 2021 | 32 | |
| 12 | 2024 | 31 | |
| 13 | 2015 | 30 | |
| 14 | 2020 | 28 | |
| 15 | 2023 | 28 | |
| 16 | 2016 | 26 | |
| 17 | 2021 | 25 | |
| 18 | 2021 | 21 | |
| 19 | 2024 | 19 | |
| 20 | 2016 | 18 |
About Weiwei Mu
Weiwei Mu is a scholar working on Biomedical Engineering, Immunology, Oncology, Molecular Biology and Materials Chemistry, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (19 papers), Immunotherapy and Immune Responses (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Silicon Nanostructures and Photoluminescence (8 papers), Immune cells in cancer (6 papers), Nanowire Synthesis and Applications (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Biomaterials (329 citations), Biomedical Engineering (616 citations), Immunology (284 citations), Oncology (205 citations) and Pharmaceutical Science (37 citations). Weiwei Mu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Na Zhang, Yongjun Liu, Qihui Chu, Shuang Liang, Shunli Fu, Tong Gao, Zipeng Zhang, Kunji Chen, Dandan Jiang and Jun Xu. Their work appears in journals such as ACS Applied Materials & Interfaces, ACS Nano, Advanced Science, Nature Communications and Nano-Micro Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.